Pomerantz Law Firm Takes On Nutex Health Inc. in Class Action Lawsuit Over Alleged Securities Violations

Pomerantz Law Firm Files Class Action Against Nutex Health Inc.

In a significant legal move, Pomerantz LLP, a recognized law firm specializing in corporate and securities class action litigation, has filed a class action lawsuit against Nutex Health Inc. (NASDAQ: NUTX) and several of its top executives. The lawsuit has been lodged with the United States District Court for the Southern District of Texas, under the docket number 25-cv-03999.

Background of the Case

The class action represents a group of investors who purchased or acquired Nutex securities between August 8, 2024, and August 14, 2025. The investors are seeking to recover damages they allege were caused by violations of federal securities laws. They claim breaches of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5, which prohibits fraudulent, misleading, or deceptive acts in connection with the purchase or sale of securities.

For investors who acquired Nutex securities during this period, the deadline to request appointment as Lead Plaintiff is October 21, 2025. Interested parties may access the full Complaint at Pomerantz Law Firm’s website. If anyone wishes to discuss the action, they should connect with Danielle Peyton, whose contact information is provided in the press release.

Overview of Nutex Health Inc.

Nutex Health Inc. is a healthcare services company that claims to be physician-led. They made their market debut through a reverse merger in April 2022 and operate across three divisions: hospital services, population health management, and real estate. Nutex primarily works as an out-of-network provider, which allows them to generate revenue through contracts with patients and third-party payers, predominantly commercial insurance. A staggering 90% of Nutex’s net patient service revenue is derived from these third-party payers.

Historically, patients treated by out-of-network providers faced